Mallinckrodt Cleared to Settle Opioid Suits, Restructure (1)

Feb. 3, 2022, 11:21 PM UTC

Pharmaceutical company Mallinckrodt Plc won court approval of its bankruptcy exit plan, clearing the way for a settlement of thousands of lawsuits related to its opioid drugs.

U.S. Bankruptcy Judge John Dorsey said in a written opinion Thursday that he would approve the plan, which calls for handing control of the company to creditors and routing opioid litigation claims to a trust set aside for their settlement and payment. A trial over the plan began in November and ended last month.

In late 2020, Mallinckrodt became the third major opioid maker to file for bankruptcy after being swamped by ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.